Trials / Completed
CompletedNCT00991848
Lidocaine on Manifestations of Fibromyalgia
Effect of Intravenous Lidocaine on Manifestations of Fibromyalgia
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Federal University of São Paulo · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Background and Objectives: Fibromyalgia is a pain syndrome characterized by numerous manifestations. The objective of this study was to evaluate the effect of the combination of intravenous lidocaine and amitriptyline on the manifestations of fibromyalgia. Methods: A prospective, randomized, double-blind, comparative study was conducted. All patient received 25 mg amitriptyline. Patients of group 1 (n = 15) received 125 mL 0.9% saline, and patients of group 2 (n = 15) received 240 mg lidocaine in 125 mL 0.9% saline once a week for 4 weeks. Manifestations were recorded before and 4 weeks after treatment. Pain intensity was rated on a verbal numerical scale.
Detailed description
Amitriptyline was chosen in the present study because it is the most widely used antidepressant with proven analgesic efficacy for the treatment of a variety of chronic pain syndromes. Amitriptyline also promotes improvement of sleep, an effect observed in the present study. Lidocaine has been widely applied by the intravenous route and patients with a variety of pain syndromes, including fibromyalgia, have reported pain relief with this technique.The dose of lidocaine employed by various investigators ranges from 1 to 5 mg/kg administered over a period of 30-60 min. The minimum effective dose is 1.5 mL/L, which is achieved with 2-5 mg/kg infused over 30-60 min. In these study, 240 mg lidocaine was administered, corresponding to about 3 mg/kg.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lidocaine | received 240 mg lidocaine diluted in 125 mL 0.9% saline. |
Timeline
- Start date
- 2005-01-01
- Primary completion
- 2007-07-01
- Completion
- 2008-09-01
- First posted
- 2009-10-08
- Last updated
- 2009-10-09
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00991848. Inclusion in this directory is not an endorsement.